Bids Are Invited For Acquisition Of Specific Materials I (Oncology)

Acquisition Of Specific Materials I (Oncology). Abatacept, Abemaciclib, Abemaciclib, Abemaciclib, Abemaciclib, Abiraterone Acetate, Acalabrutinib, Zoledronic Acid, Zoledronic Acid, Adalimumab, Adalimumab, Afatinib Dimaleate, Afatinib Dimaleate, Aflibercept, Alectinib, Interferon, Thyrotropin Alfa, Alpelisib, Alpelisib, Anagrelide Clo Hydrate,Anastrozole,Apalutamide ,Atezolizumab,Avelumab,Axitinib,Axitinib,Azacitidine,Azathioprine,Belimumab,Belimumab,Belinostat,Bendamustine,Bendamustine,Bevacizumab,Bevacizumab,Bicalutamide,Bleomycin Sulfate,Blinatumomab,Bortezomib,Brentuximab,Brigatinib,Brigatinib E, Cabazitaxel, Cabozantinib, Cabozantinib ,Cabozantinib,Canakinumab,Capecitabine,Capecitabine,Caplacizumab,Carboplatin,Carboplatin,Carboplatin,Ferric Carboxymaltose,Carfilzomib,Cemiplimab,Certolizumab Pegol,Cetuximab,Cyclophosphamide,Cyclophosphamide,Cyclophosphamide,Cyclosporine,Cyclosporine,Cyclosporine, Cyproterone Acetate,Cisplatin,Cisplatin,Cytarabine, Cytarabine,Cladribine,Chlorambucil,Cobimetinib Hemifumarate,Crizotinib,Crizotinib,Dabrafenib,Dabrafenib,Dacarbazine,Danazol,Danazol,Daratumumab,Daratumumab,Daratumumab,Darolutamide,Dasatinib,Dasatinib,Daunorubicin